ReviewOncoTargets and therapy2013

Should a Toll-like receptor 4 (TLR-4) agonist or antagonist be designed to treat cancer? TLR-4: its expression and effects in the ten most common cancers.

Chun Wai Mai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.